Larvol Delta - Altimmune-to-Announce-Topline-24-Week-Results-from-its-IMPACT-Phase-2b-Trial-of-Pemvidutide-in-the-Treatment-of-MASH-on-Thursday-June-26

pemvidutide (ALT-801) - Altimmune

https://www.globenewswire.com/news-release/2025/06/25/3105503/0/en/Altimmune-to-Announce-Topline-24-Week-Results-from-its-IMPACT-Phase-2b-Trial-of-Pemvidutide-in-the-Treatment-of-MASH-on-Thursday-June-26.html

Jun 25, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next